BiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025

Benzinga08-15

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2459144452?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-15 18:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2459144452","market":"hk","top_or_hot":-1,"title":"BiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025","media":"Benzinga","content":"<html><body><p>BiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-15 18:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/earnings/24/08/40389775/biomx-q2-eps-0-07-up-from-0-12-yoy-cash-balance-short-term-deposits-and-restricted-cash-as-of-june-><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025</p>\n\n<a href=\"https://www.benzinga.com/news/earnings/24/08/40389775/biomx-q2-eps-0-07-up-from-0-12-yoy-cash-balance-short-term-deposits-and-restricted-cash-as-of-june-\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PHGE","symbol_name":"BiomX Inc.","start_time":0,"source_url":"https://www.benzinga.com/news/earnings/24/08/40389775/biomx-q2-eps-0-07-up-from-0-12-yoy-cash-balance-short-term-deposits-and-restricted-cash-as-of-june-","article_id":"2459144452","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2459144452","pubTimestamp":1723718003,"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"BiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PHGE":"BiomX Inc."},"translate_title":"BiomX第二季度每股收益为(0.07)美元，高于同比(0.12)美元；截至2024年6月30日，现金余额、短期存款和限制性现金为3,270万美元，足以为其2025年第四季度的运营提供资金","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHGE":0.9},"content_text":"BiomX Q2 EPS $(0.07) Up From $(0.12) YoY; Cash Balance, Short-term Deposits And Restricted Cash As Of June 30, 2024, Were $32.7M, Sufficient To Fund Its Operations Through The Fourth Quarter Of 2025","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2459144452"}